4.7 Article

Rising Incidence of Type 1 Diabetes Is Associated With Altered Immunophenotype at Diagnosis

期刊

DIABETES
卷 61, 期 3, 页码 683-686

出版社

AMER DIABETES ASSOC
DOI: 10.2337/db11-0962

关键词

-

资金

  1. Medical Research Council, London, U.K
  2. Medical Research Council
  3. Diabetes UK
  4. Wellcome Trust

向作者/读者索取更多资源

The incidence of type 1 diabetes has increased rapidly over recent decades, particularly in young children. We aimed to determine whether this rise was associated with changes in patterns of humoral islet autoimmunity at diagnosis. Autoantibodies to insulin (IAA), GAD (GADA), islet antigen-2 (IA-2A), and zinc transporter 8 (ZnT8A) were measured by radioimmunoassay in sera collected from children and young adults with newly diagnosed type 1 diabetes between 1985 and 2002. The influence of date of diagnosis on prevalence and level of autoantibodies was investigated by logistic regression with adjustment for age and HLA class II genetic risk. Prevalence of IA-2A and ZnT8A increased significantly over the period studied, and this was mirrored by raised levels of IA-2A, ZnT8A, and IA-2 beta autoantibodies (IA-2 beta A). IAA and GADA prevalence and levels did not change. Increases in IA-2A, ZnT8A, and IA-2 beta A at diagnosis during a period of rising incidence suggest that the process leading to type 1 diabetes is now characterized by a more intense humoral autoimmune response. Understanding how changes in environment or lifestyle alter the humoral autoimmune response to islet antigens should help explain why the incidence of type 1 diabetes is increasing and may suggest new strategies for preventing disease. Diabetes 61:683-686, 2012

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes

Alistair J. K. Williams, Vito Lampasona, Michael Schlosser, Patricia W. Mueller, David L. Pittman, William E. Winter, Beena Akolkar, Rebecca Wyatt, Cristina Brigatti, Stephanie Krause, Peter Achenbach

DIABETES (2015)

Article Endocrinology & Metabolism

Novel Association Between Immune-Mediated Susceptibility Loci and Persistent Autoantibody Positivity in Type 1 Diabetes

Caroline A. Brorsson, Suna Onengut, Wei-Min Chen, Janet Wenzlau, Liping Yu, Peter Baker, Alistair J. K. Williams, Polly J. Bingley, John C. Hutton, George S. Eisenbarth, Patrick Concannon, Stephen S. Rich, Flemming Pociot

DIABETES (2015)

Article Endocrinology & Metabolism

Attenuated humoral responses in HLA-A*24-positive individuals at risk of type 1 diabetes

Jody Ye, Anna E. Long, James A. Pearson, Hazel Taylor, Polly J. Bingley, Alistair J. K. Williams, Kathleen M. Gillespie

DIABETOLOGIA (2015)

Article Endocrinology & Metabolism

Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes

Georgina M. Williams, Anna E. Long, Isabel V. Wilson, Rachel J. Aitken, Rebecca C. Wyatt, Timothy J. McDonald, F. Susan Wong, Andrew T. Hattersley, Alistair J. K. Williams, Polly J. Bingley, Kathleen M. Gillespie

DIABETOLOGIA (2016)

Article Endocrinology & Metabolism

The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes

R. C. Wyatt, C. Brigatti, D. Liberati, S. L. Grace, B. T. Gillard, A. E. Long, I. Marzinotto, D. K. Shoemark, K. A. Chandler, P. Achenbach, K. M. Gillespie, L. Piemonti, V. Lampasona, A. J. K. Williams

DIABETIC MEDICINE (2018)

Article Endocrinology & Metabolism

The Core Cysteines, (C909) of Islet Antigen-2 and (C945) of Islet Antigen-2β, Are Crucial to Autoantibody Binding in Type 1 Diabetes

Karen T. Elvers, Ivey Geoghegan, Debbie K. Shoemark, Vito Lampasona, Polly J. Bingley, Alistair J. K. Williams

DIABETES (2013)

Editorial Material Endocrinology & Metabolism

Following the Fate of the Failing β-Cell: New Insights From First-Phase Insulin Responses

Alistair J. K. Williams, Anna E. Long

DIABETES (2013)

Editorial Material Endocrinology & Metabolism

Islet Autoantibody Testing: An End to the Trials and Tribulations?

Polly J. Bingley, Alistair J. K. Williams

DIABETES (2013)

Article Endocrinology & Metabolism

Humoral Responses to Islet Antigen-2 and Zinc Transporter 8 Are Attenuated in Patients Carrying HLA-A*24 Alleles at the Onset of Type 1 Diabetes

Anna E. Long, Kathleen M. Gillespie, Rachel J. Aitken, Julia C. Goode, Polly J. Bingley, Alistair J. K. Williams

DIABETES (2013)

Article Endocrinology & Metabolism

Early Onset of Diabetes in the Proband Is the Major Determinant of Risk in HLA DR3-DQ2/DR4-DQ8 Siblings

Kathleen M. Gillespie, Rachel J. Aitken, Isabel Wilson, Alistair J. K. Williams, Polly J. Bingley

DIABETES (2014)

Review Endocrinology & Metabolism

Persistence of islet autoantibodies after diagnosis in type 1 diabetes

Anna E. Long, Gifty George, Claire L. Williams

Summary: Islet autoantibodies are reliable biomarkers for identifying individuals at high risk of developing type 1 diabetes. Their prevalence and persistence after diagnosis are key factors in understanding the progression of the disease and selecting appropriate interventions.

DIABETIC MEDICINE (2021)

Article Endocrinology & Metabolism

Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective

Emily K. Sims, Rachel E. J. Besser, Colin Dayan, Cristy Geno Rasmussen, Carla Greenbaum, Kurt J. Griffin, William Hagopian, Mikael Knip, Anna E. Long, Frank Martin, Chantal Mathieu, Marian Rewers, Andrea K. Steck, John M. Wentworth, Stephen S. Rich, Olga Kordonouri, Anette-Gabriele Ziegler, Kevan C. Herold

Summary: Most screening programs for type 1 diabetes identify individuals at risk through relatives, but many patients don't have a family history. Recent advancements in disease-modifying therapies have sparked interest in population screening. Existing programs rely on genetic or autoantibody screening, which have provided valuable insights into disease progression and screening timing.

DIABETES (2022)

Letter Endocrinology & Metabolism

Diagnosing Type 1 diabetes in adults: Guidance from the UK T1D Immunotherapy consortium

Danijela Tatovic, Angus G. Jones, Carol Evans, Anna E. Long, Kathleen Gillespie, Rachel E. J. Besser, Richard David Leslie, Colin M. Dayan

DIABETIC MEDICINE (2022)

暂无数据